At FoodPharma™, we believe in world-class quality, innovation, and integrity as our guiding principles. We specialize in leading-edge, plant-based, food-form delivery systems with ongoing innovations in food science and nutrient delivery that enhance the quality and performance of our functional food products.
Our team of expert food scientists have extensive experience in developing and manufacturing customers’ products concept into viable, shelf-stable products. Our skilled food scientists work with a vast library of archived formulas that have been previously commercialized and have proven shelf performance. These base formulas allow us to diversify into new novel formulations meeting modern retail design requirements.
Custom functional formulations are available by design.
Our patent pending QuadOralTM Absorption Technology contains plant-derived saccharides and natural permeation enhancers which facilitate the transport and absorption of small molecules to the bloodstream when chewed and swallowed
 This application claims priority from United States Provisional Patent Application No.62/696,995, filed July 12, 2018 and entitled “A NOVEL, SACCHARIDE-BASED, ORAL MUCOADHESIVE DELIVERY SYSTEM FOR FAST-ACTING, NEUROTROPHIC AND NEUROPROTECTIVE BENEFITS,” the disclosures of which are hereby incorporated entirely herein by reference.
This invention generally relates to delivery systems, and more particularly to a saccharide-based oral mucoadhesive delivery system for administration of neurotrophic and neuroprotective compositions.
The oral cavity is an ideal-site for small molecule, nutrient/nutraceutical delivery to the central nervous system (CNS) and systemic circulation due to the highly-vascularized, oral mucosa, near-neutral pH conditions, close proximity to the brain, and avoidance of gastric degradation and the first-pass effect. The rich-blood supply of the oral mucosa and “sticky”, mucoadhesive properties of this novel, saccharide-based, delivery system allows for the efficient absorption of small molecules across several highly-vascularized surfaces including the gingival, sublingual, soft-palatal, and buccal mucosa. Herein, I introduce a novel, saccharide-based, food-form, palatable, easy-to-administer, oral delivery system that attaches to these four, highly-absorptive surfaces for a longer contact-duration than current orally-available formulas resulting in greater, small molecule bioavailability, and a more rapid, therapeutic effect. This invention represents the next-generation in optimized, highly- efficacious, small molecule delivery systems for CNS-related conditions that moves one-step closer in approximating intravenous injection in systemic bioavailability and therapeutic onset.